16 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
ABT Abbott Laboratories $67.67 $118.71B N/A
Article Searches
Medical Instruments' Oct 31 Earnings Roster: IDXX, ABMD & More http://www.zacks.com/stock/news/593569/medical-instruments-oct-31-earnings-roster-idxx-abmd-more?cid=CS-ZC-FT-analyst_blog:_earnings_preview_-_esp|earnings_preview_-_esp-593569 Oct 30, 2019 - Earnings and revenues for the Medical Instruments sector in the third quarter are likely to have declined sequentially. Read to know how a few companies from the sector might have fared in the period.
Medical Products' Nov 7 Earnings Roster: ABC, CAH & More http://www.zacks.com/stock/news/606407/medical-products-nov-7-earnings-roster-abc-cah-more?cid=CS-ZC-FT-analyst_blog:_earnings_preview_-_esp|earnings_preview_-_esp-606407 Nov 06, 2019 - Despite the ongoing US-China trade war, solid growth in emerging markets is likely to have contributed to the performance of the players in the medical products space this earnings season.
3 Dividend-Paying Large Cap Pharma Stocks to Consider for 2020 http://www.zacks.com/stock/news/690807/3-dividend-paying-large-cap-pharma-stocks-to-consider-for-2020?cid=CS-ZC-FT-stocks_in_the_news|investment_ideas-690807 Dec 27, 2019 - The stock market continued its end of the year rally Friday as the three major indices all hit new intraday highs.
The 3 Best Healthcare Stocks to Buy for 2020 https://www.fool.com/investing/2019/12/29/the-3-best-healthcare-stocks-to-buy-for-2020.aspx?source=iedfolrf0000001 Dec 29, 2019 - These three healthcare stocks have all the ingredients needed to cook up great returns in the new year.
Abbott's Less-Invasive Surgery for Heart Pump Gets FDA Nod http://www.zacks.com/stock/news/708050/abbotts-less-invasive-surgery-for-heart-pump-gets-fda-nod?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-708050 Jan 08, 2020 - Abbott's (ABT) less invasive approach for heart surgery for its heart pump gets the FDA clearance, thus paving the way for avoiding open heart surgeries.
Abbott (ABT) Reports Next Week: Wall Street Expects Earnings Growth http://www.zacks.com/stock/news/719419/abbott-abt-reports-next-week-wall-street-expects-earnings-growth?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-719419 Jan 15, 2020 - Abbott (ABT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Abbott (ABT) Q4 Earnings Match Estimates, Revenues Beat Mark http://www.zacks.com/stock/news/729187/abbott-abt-q4-earnings-match-estimates-revenues-beat-mark?cid=CS-ZC-FT-analyst_blog|earnings_article-729187 Jan 22, 2020 - We are upbeat about Abbott's (ABT) strong and consistent EPD and Medical Devices performances, organically.
Chicago Econ Numbers & More Q4 Earnings: JNJ, ABT, FITB http://www.zacks.com/stock/news/729277/chicago-econ-numbers-more-q4-earnings-jnj-abt-fitb?cid=CS-ZC-FT-ahead_of_wall_street-729277 Jan 22, 2020 - Certain weeks of the year are rife with important information for the stock market. This is not one of those weeks.
Abbott Laboratories (ABT) CEO Miles White on Q4 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4318424-abbott-laboratories-abt-ceo-miles-white-on-q4-2019-results-earnings-call-transcript?source=feed_sector_healthcare Jan 22, 2020 - Abbott Laboratories (NYSE:ABT) Q4 2019 Earnings Conference Call January 22, 2020 09:30 ET Company Participants Scott Leinenweber - VP, IR, Licensing & Acquisitions Miles White - Chairman & CEO
3 Medical Product Stocks Likely to Beat This Earnings Season http://www.zacks.com/stock/news/602463/3-medical-product-stocks-likely-to-beat-this-earnings-season?cid=CS-ZC-FT-earnings_esp-602463 Nov 04, 2019 - Despite the ongoing US-China trade war, solid growth in emerging markets is likely to have contributed to the performance of the players in the medical products space this earnings season.

Pages: 12

Page 1